In response t o vessel injury or exposure t o different substances, platelets undergo activation which consists of shape changes, formation of cellular pseudopodia, aggregation, and secretion. These dramatic changes are accompanied by cycles of actin depolymerization and polymerization. Previous work has shown the presence in platelets of gelsolin and scinderin, two Ca2+-dependent F-actin severing proteins. Recent published evidence suggests that scinderin is a component of the exocytotic machinery in chromaffin cells. The present work describes the preparation of recombinant scinderin and peptides Sc-ABP, and Sc-ABP, with sequences corresponding t o t w o actin-binding sites of scinderin. Recombinant scinderin and peptides Sc-ABP, and Sc-ABP, were tested for their effects on Ca2+-induced serotonin release from digitonin permeabilized platelets. The results LATELET ACTIVATION consists of shape changes, formation of cellular pseudopodia, aggregation, and secretion.'-3 A large body of biochemical and morphologic evidence suggests that actin polymerizes and depolymerizes in response to various stimuli that activate platelet^.^" Previous work has shown the presence in platelets of gelsolin8,y and scinderin," two Ca2'-dependent F-actin severing proteins that control actin network dynamics. Gelsolin is found practically in all cell types," whereas scinderin is found only in secretory cell^.'^^'^^^^ Scinderin was first discovered in chromaffin cells" and its gene has been recently cloned in our lab~ratory.'~ Recent published evidence also suggests that scinderin is a component of the exocytotic machinery in chromaffin cell^.'^,'^ Recombinant scinderin and peptides Sc-ABP, and Sc-ABP, with sequences corresponding to two actin-binding sites of scinderin have been prepared and tested for their effects on Ca*+-induced serotonin release from digitonin permeabilized platelets. Here we show that recombinant scinderin potentiates Ca2+-evoked serotonin release, an effect blocked in the presence of Sc-ABP,, Sc-ABP2, exogenous actin, or the addition of phosphatidylinosi- indicated that recombinant scinderin potentiates Ca2+-evoked serotonin release, an effect blocked in the presence of Sc-MP,. Sc-ABP,, exogenous y-actin, or the addition of phosphatidylinositol 4.5-bisphosphate (PIP,). In the presence of a mismatched peptide ("P) the potentiating effect of recombinant scinderin was not affected. Moreover, Se-ABP,, Sc-ABP,, and y-actin inhibited Ca2'-induced release of serotonin in the absence of recombinant scinderin, suggesting an inhibition of platelet endogenous scinderin. MMP was ineffective under these conditions. The results suggest that F-actin disassembly, perhaps at a specific site, is required for platelet secretion and that scinderin might be an important component of the exocytotic machinery in platelets. 0 7996 by The American Society of Hematology. to1 4,5-bisphosphate. The results suggest the involvement of scinderin mediated F-actin disassembly in platelet secretion.
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indicated that recombinant scinderin potentiates Ca2+-evoked serotonin release, an effect blocked in the presence of Sc-MP,. Sc-ABP,, exogenous y-actin, or the addition of phosphatidylinositol 4.5-bisphosphate (PIP,). In the presence of a mismatched peptide ("P) the potentiating effect of recombinant scinderin was not affected. Moreover, Se-ABP,, Sc-ABP,, and y-actin inhibited Ca2'-induced release of serotonin in the absence of recombinant scinderin, suggesting an inhibition of platelet endogenous scinderin. MMP was ineffective under these conditions. The results suggest that F-actin disassembly, perhaps at a specific site, is required for platelet secretion and that scinderin might be an important component of the exocytotic machinery in platelets. 0 7996 by The American Society of Hematology. to1 4,5-bisphosphate. The results suggest the involvement of scinderin mediated F-actin disassembly in platelet secretion.
MATERIALS AND METHODS
Source of platelets. Platelet-rich plasma was obtained from the blood bank of Ottawa Red Cross and centrifuged at 200g for 15 minutes to eliminate red blood cells. The supernatant thus obtained was centrifuged at 800g for 15 minutes to obtain a platelet sediment.
Platelet permeabilization and labeling of serotonin stores. The platelet pellet was resuspended in Ca'+-free Locke's solution (mmoll L: NaCI, 154; KCI, 2.6; K2HP04, 2.14; KH2P04, 0.85; MgClz, 1.2; glucose, IO; and EGTA, 2.0; pH 7.2). After a wash with Locke's solution, the platelet concentration was adjusted to 7.5 X IOR/mL. Platelets were then incubated at 37°C for 90 minutes with 0.6 nmol ['H]S-HT/mL (specific activity = 25.4 Ci/mmol; DuPont, Boston, MA)." After incubation, the [3H]5-HT-labeled platelets were washed by incubation with six changes of I rnL Caz+-free Locke's solution over a 60-minute period before the experiments were commenced. ['H]5-HT-labeled platelets were permeabilized by treatment during 5 minutes with 15 pmoVL digitonin in K+-glutamate buffer (mmol/L: MgC12, 12.5; K+-glutamate, 160; EGTA, 2.5; EDTA, 2.5; adenosine triphosphate (ATP), 5; HEPES, 20; pH 7.4)." After permeabilization, platelets were centrifuged at 90013 for 2 minutes (4°C) and then resuspended in K+-glutamate buffer. Ca" concentrations required to give appropriate pCa values were calculated as previously described." Serotonin release studies. Briefly, samples (100 pL) containing 7.5 x lo7 permeabilized platelets in K+-glutamate buffer were stimulated with 10 pmol/L Ca2+ for 45 seconds in the absence or presence of recombinant scindetin, thioredoxin, or scinderin-derived actin binding peptides. Release experiments were terminated by addition of an equal volume of 6% glutaraldehyde in 0.1 mom phosphate buffer (pH 7.4). Preparations were centrifuged at 900g for 2 minutes. Source of antibodies. Polyclonal antibodies were raised in rabbits against purified bovine ~cinderin.'~ Preparation of recombinant scinderin. The Thioredoxin ThioFusion System (Invitrogen, San Diego, CA) was used for the expression and purification of the fusion protein. Scinderin cDNA was subcloned in expression vector pTrxFus using Sma I restriction site (blunt ends) of the vector and Sma I and Not I (Klenow filled in) of scinderin cDNA previously cloned in pGEX 4T2 (Pharmacia, Uppsala, Sweden).I4 Recombinant plasmids were then transfected into the host Escherichia coli GI698. Transformed E coli were grown overnight at 29°C in 100 mL of Rich Medium (Invitrogen, San Diego, CA) medium containing 100 pg ampicillin/nL. The culture was diluted 10 times with induction medium and grown for 4 hours before induction with tryptophan (100 pg/mL; final concentration). After a 2-hour incubation at 2YC, the optical density55o (OD,,,) was measured and cells were sedimented. Using osmotic shock solution 1 (20 mmol/L Tris-HCI, pH 8; 2.5 mmoVL EDTA; 20% sucrose) the cells were resuspended to an OD,,, of 5, incubated for 10 minutes on ice and centrifuged at 10, OOOg for 10 minutes. The supernatant was decanted and the cell pellet was resuspended in osmotic shock solution 2 (20 mmol/L Tris-HCI, pH 8; 2.5 mmol/L EDTA), incubated on ice for 10 minutes and centrifuged at 10,ooOg for IO minnutes. The supernatant ("shock fluid") was dialyzed against buffer The binding of scinderin to actin allowed the retention of the fusion protein complex thioredoxin-scinderin in the affinity column. The actin-DNAse I-Sepharose 4B (Pharmacia) affinity column was prepared as described previously.2o The column was washed with buffer A before the application of the dialyzed shock fluid. The recombinant protein was eluted from the column with buffer B (Ca2+-free buffer A containing 10 mmol/L EGTA).I4 The preparation was dialyzed against EGTA-free K'-glutamate buffer and then lyophilized. Purified thioredoxin (TR) was prepared using expression vector pTrx (Invitrogen). This plasmid encoding wild-type TR was transfected into E coli GI698. Transformed E coli G1698 was processed to obtain "shock fluid" as described above.
Electrophoresis. All protein samples were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting using an antibody against native scinderin.I3 Monodimensional SDS-PAGE were performed according to Doucet and Trifar6."
RESULTS
Recombinant scinderin.
Full-length chromaffin cell scinderin cDNA was subcloned into expression vector pTrxFus using restriction site Sma I of the vector and Sma I and Not I of the scinderin cDNA. The recombinant vector was transfected into E coli G1698 to express the corresponding fusion protein (Thioredoxin-Scinderin). Recombinant vectors carried the full-length scinderin clone. Transformed E coli G1698 showed the presence of a thioredoxin-scinderin complex only when induced with tryptophan. Lysates obtained from induced preparations showed in immunoblots from SDS-PAGE a new protein band of approximately 92 kD which cross-reacted with an antibody against native scinderinI3 (Fig lB, lane 4' ). Tryptophan induction of parenteral (nonrecombinant) vectors failed to show the 92-kD band (Fig lB, lane 2' ) but they showed an increase in the 11.7-kD thioredoxin band (Fig lA, lane 2) . Aliquots of lysates of preparations shown in lanes 3 and 4 ( Fig 1A) were applied in the presence of Ca2+ to actin-DNase Sepharose 4B columns. SDS-PAGE and immunoblots of Ca2+-free (EGTA) eluates from the columns showed that only the same 92-kD protein was retained by the affinity column and subsequently eluted with Ca2+-free buffer (Fig lA, lane 6) . This protein showed cross-reactivity with the antibody against native scinderin (Fig lB, lane 6') . The results indicate that a full-length scinderin fusion protein was obtained and that this protein, which was immunologically identical to native scinderin, was bound to actin in a Ca2+-dependent manner. The results also suggest that recombinant scinderin interacts with actin in a similar manner to native scinderin.
Effect of recombinant scinderin on Ca2+-induced serotonin release. Increasing concentrations of purified recombinant fusion protein were incubated with digitonin permeabilized platelets previously loaded with [3H]5-hydroxytryptamine (5-HT). Serotonin release was induced by 45-second exposure to 10 pmol/L Ca". Under these conditions, recombinant scinderin produced a concentration dependent increase in Ca2+-evoked 5-HT release (Fig 2) . Moreover, to rule out the participation of TR in the observed effects of the recombinant scinderin, a plasmid pTrx, encoding the wild type of TR was subcloned into E coli G1698 (Fig lA, lanes l and 2) . TR was isolated from transformed E coli and tested on Ca2+-evoked 5-HT release. TR at the concentration of either 0.5 or 5 pmol/L had no effect on Ca2+ induced 5-HT release or on the potentiating effect of recombinant scinderin (Fig 3) .
Effects of scinderin actin-binding peptides and of y-actin on Ca2+-induced serotonin release. The potentiation of 5-HT release by recombinant scinderin seems to be caused by an increased F-actin severing activity of scinderin, because the ability of scinderin to increase 5-HT release was inhibited in the presence of 10 pmoVL of scinderin actin binding peptide 1 (Sc-ABP, ; AAAIFTVQMDDYL; 90.2% t-11% inhibition), scinderin actin binding peptide 2 (Sc-ABP,; RLLHVKGRR; 81.4% 2 7% inhibition) (Fig 4A and B) or by the addition to the incubation media of 10 pmol/L chicken gizzard y-actin (74.4% t-9% inhibition) (Fig 4B) . Exogenous actin, Sc-ABP,, and Sc-ABP, also decreased Ca2+-induced 5-HT release in the absence of recombinant scinderin (Fig 4B) , thus suggesting inhibition of endogenous scinderin activity. The presence of either bovine serum albumin (BSA) or a mismatched peptide (MMP) (QIVIHLNSKDGSC) in the incubation media did not modify Ca2+-evoked 5-HT release either in the presence or absence of recombinant scinderin (Figs 3 and 4B) . No homology for the MMP sequence was found in the sequences stored in the EMBL data library.
Effect of phosphatidylinositol 4,5-bisphosphate (PIP2) on recombinant scinderin activiry. PIPp binds to and modulates the severing activity of scinderin. '4,22 Therefore, experiments tested the effect of PIP2 on the potentiation of 5-HT release induced by recombinant scinderin. The ability of scinderin to increase Ca2+-evoked 5-HT release was inhibited by 10 pmoyL PIP2. However, the inhibitor effect of PIP2 was greater when, before Ca2+ stimulation, the preparation of permeabilized platelets was preincubated for 5 minutes with PIP2 in a Ca2+-free medium containing recombinant scinderin (Fig 5) . dopodia and central contractile gel) during platelet activation.5 Therefore, it is quite possible that scinderin and gelsolin are separately involved in controlling actin filament length in platelets. Moreover. the fact that scinderin is present only in cells with high secretory activity," would suggest a role for this protein in
We have previously shown that during chromaffin cell stimulation, a Ca"-dependent redistribution of cortical scinderin together with cortical F-actin disassembly is observed." These events precede exocytosis and are necessary requirements for secretion to ocCUr.15.1h Moreover, chromaffin cell cortical F-actin dynamics control the size of the release-ready secretory vesicle pool." On the other hand, it has been suggested that during platelet aggregation, actin polymerizes and the content of the secretory granules is released to the cell exterior.'.s However, the experiments with Sc-ABP, and Sc-ABP2 suggest that when the peptides are bound to actin occupying either one of the binding sites for scinderin, this protein fails to produce both, the severing of F-actin and the potentiation of S-HT release. These sites which are present in domains I and 2 of scinderin 23 ( Fig 4A) are necessary for its binding to actin and for its severing activity." Furthermore, Sc-ABP,, Sc-ABP2, and yactin inhibited Ca"-evoked serotonin release in the absence of' recombinant scinderin suggesting an inhibition of platelet endogenous scinderin. These observations together with the potentiation of S-HT release by recombinant scinderin in the absence of Sc-ABP, or Sc-ABP2, suggest as in chromaffin cells, that F-actin disassembly, perhaps at a specific site, is required for platelet secretion and that scinderin might be an important component of the exocytotic machinery in platelets. Moreover, the increase in S-HT release in response to Ca'" stimulation observed in the presence of recombinant scinderin might be the result, as in the case of chromaffin cells.'s of an increase in the number of secretory vesicles positioned at release sites as a consequence of an enhanced scinderin evoked F-actin disassembly. Published work indicates that PIP2 modulates the activity of many actin regulatory proteins'" including scinderin."." Scinderin has the ability to interact with both PIP? and phosphatidylserine in a Ca"-dependent manner."
However, in the presence of IO pmol/L Ca" scinderin has greater affinity for actin than for phosphatidylserine or PIP2." This would explain the lack of inhibition by PIP, of Ca"-induced release of serotonin in the absence of recombinant scinderin and the need of a preincubation period with PIPz in a Ca"-free solution (Fig S) For personal use only. on November 16, 2017. by guest www.bloodjournal.org From suggest that activation of the PIP, pathway during platelet stimulation might release scinderin from binding sites and remove its inhibition by PIP2.
